

Convoke Bio
Convoke Bio is building an AI-native operating system specifically for the biopharma lifecycle. The platform ingests and synthesizes vast amounts of unstructured data - from clinical trials to regulatory documents - to streamline the commercialization process. Convoke is positioned to reduce the administrative friction in drug development, helping teams make faster, data-driven decisions during critical launch phases. The approach compresses traditional R&D timelines, offering systemic cost reductions in therapeutic development and biological engineering.
Biotechnology
·
Hybrid·
11-50·
$8.6M Seed
















